Diabetes 54:1264-1276, 2005
© 2005 by the American Diabetes Association, Inc.
Insulin Signaling in the Central Nervous SystemA Critical Role in Metabolic Homeostasis and Disease From C. elegans to Humans
Daniel Porte, Jr.1,2,3,
Denis G. Baskin3, and
Michael W. Schwartz3,4,5
1 Division of Metabolism, Diabetes, and Endocrinology, University of California San Diego, San Diego, California
2 Veterans Affairs San Diego Health Care System, San Diego, California
3 Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington
4 Veterans Affairs Puget Sound Health Care System, Seattle, Washington
5 Harborview Medical Center, Seattle, Washington
Insulin and its signaling systems are implicated in both central and peripheral mechanisms governing the ingestion, distribution, metabolism, and storage of nutrients in organisms ranging from worms to humans. Input from the environment regarding the availability and type of nutrients is sensed and integrated with humoral information (provided in part by insulin) regarding the sufficiency of body fat stores. In response to these afferent inputs, neuronal pathways are activated that influence energy flux and nutrient metabolism in the body and ensure reproductive competency. Growing evidence supports the hypothesis that reduced central nervous system insulin signaling from either defective secretion or action contributes to the pathogenesis of common metabolic disorders, including diabetes and obesity, and may therefore help to explain the close association between these two disorders. These considerations implicate insulin action in the brain, an organ previously considered to be insulin independent, as a key determinant of both glucose and energy homeostasis.
Address correspondence and reprint requests to Daniel Porte, Jr, MD, VA San Diego Health Care System (111G), 3350 La Jolla Village Dr., San Diego, CA 92161. E-mail: dporte{at}ucsd.edu
Abbreviations:
AGE, advanced glycation end product; AgRP, Agouti-related peptide; BAT, brown adipose tissue; CART, cocaine and amphetamine-regulated transcript; CNS, central nervous system; ICV, intracerebroventricular; IRS, insulin receptor substrate; JAK-STAT, Janus kinase-signal transducers and activators of transcription; KATP channel, ATP-sensitive K+ channel; NPY, neuropeptide Y; PI3K, phosphatidylinositol 3-OH kinase; POMC, precursor proopiomelanocortin; PPY3–36, peptide YY3–36; SNS, sympathetic nervous system; SOCS3, suppressor of cytokine signaling 3

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. M. van den Hoek, C. van Heijningen, J. P. Schroder-van der Elst, D. M. Ouwens, L. M. Havekes, J. A. Romijn, A. Kalsbeek, and H. Pijl
Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation
Diabetes,
September 1, 2008;
57(9):
2304 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vidarsdottir, P. A.M. Smeets, D. L. Eichelsheim, M. J.P. van Osch, M. A. Viergever, J. A. Romijn, J. van der Grond, and H. Pijl
Glucose Ingestion Fails to Inhibit Hypothalamic Neuronal Activity in Patients With Type 2 Diabetes
Diabetes,
October 1, 2007;
56(10):
2547 - 2550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. M. Smeets, S. Vidarsdottir, C. de Graaf, A. Stafleu, M. J. P. van Osch, M. A. Viergever, H. Pijl, and J. van der Grond
Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E754 - E758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Callaway, H. D. McIntyre, M. O'Callaghan, G. M. Williams, J. M. Najman, and D. A. Lawlor
The Association of Hypertensive Disorders of Pregnancy with Weight Gain over the Subsequent 21 Years: Findings from a Prospective Cohort Study
Am. J. Epidemiol.,
August 15, 2007;
166(4):
421 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Denley, J. M. Carroll, G. V. Brierley, L. Cosgrove, J. Wallace, B. Forbes, and C. T. Roberts Jr.
Differential Activation of Insulin Receptor Substrates 1 and 2 by Insulin-Like Growth Factor-Activated Insulin Receptors
Mol. Cell. Biol.,
May 15, 2007;
27(10):
3569 - 3577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Hay and K. Docherty
Comparative Analysis of Insulin Gene Promoters: Implications for Diabetes Research
Diabetes,
December 1, 2006;
55(12):
3201 - 3213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Marty, I. Bady, and B. Thorens
Distinct Classes of Central GLUT2-Dependent Sensors Control Counterregulation and Feeding
Diabetes,
December 1, 2006;
55(Supplement_2):
S108 - S113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Woods, S. C. Benoit, and D. J. Clegg
The Brain-Gut-Islet Connection
Diabetes,
December 1, 2006;
55(Supplement_2):
S114 - S121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Porte Jr.
Central Regulation of Energy Homeostasis: The Key Role of Insulin
Diabetes,
December 1, 2006;
55(Supplement_2):
S155 - S160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-T. T. Nguyen, P. Tajmir, C. H. Lin, N. Liadis, X.-D. Zhu, M. Eweida, G. Tolasa-Karaman, F. Cai, R. Wang, T. Kitamura, et al.
Essential Role of Pten in Body Size Determination and Pancreatic {beta}-Cell Homeostasis In Vivo
Mol. Cell. Biol.,
June 15, 2006;
26(12):
4511 - 4518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L DiPietro and N S Stachenfeld
The myth of the female athlete triad
Br. J. Sports Med.,
June 1, 2006;
40(6):
490 - 493.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|